MovDisordV3, Ncbi, Merge, bibRecord, 000F50

An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.

Identifieur interne : 000F50 ( Ncbi/Merge ); précédent : 000F49; suivant : 000F51

An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.

Auteurs : Eng-King Tan [Singapour] ; Su-Chin Ho ; Leonard Koh ; Ratnagopal Pavanni

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2004.

RBID : pubmed:15378680

English descriptors

KwdEn :
- Ferritins (blood), Humans, Hypothyroidism (drug therapy), Iron (therapeutic use), Male, Middle Aged, Neurologic Examination, Polysomnography, Restless Legs Syndrome (chemically induced), Restless Legs Syndrome (diagnosis), Risk Factors, Thyroid Function Tests, Thyroiditis, Autoimmune (drug therapy), Thyroxine (adverse effects), Thyroxine (therapeutic use).
MESH :
- chemical , adverse effects : Thyroxine.
- chemical , blood : Ferritins.
- chemically induced : Restless Legs Syndrome.
- diagnosis : Restless Legs Syndrome.
- drug therapy : Hypothyroidism, Thyroiditis, Autoimmune.
- chemical , therapeutic use : Iron, Thyroxine.
- Humans, Male, Middle Aged, Neurologic Examination, Polysomnography, Risk Factors, Thyroid Function Tests.

Abstract

We report on the cause and effect relationship of restless legs syndrome (RLS) with L-thyroxine treatment in a hypothyroid patient with low serum ferritin. Upon challenge and withdrawal of L-thyroxine, there was a significant change in the International Restless Legs Syndrome Study Group severity score (26/40 to 6/40), the periodic limb movements (PMLS) index (20/hour to 10/hour), the number of arousals due to PLMS (59 to 22), sleep efficiency (74 to 85%), and biochemical parameters. RLS symptoms can complicate thyroxine replacement in at-risk hypothyroid patients with low serum ferritin. Early diagnosis and iron replacement could significantly reduce patient morbidity.

DOI: 10.1002/mds.20219
PubMed: 15378680

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003338
to stream PubMed, to step Curation: 003338
to stream PubMed, to step Checkpoint: 003567

Links to Exploration step

pubmed:15378680

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.</title>
<author><name sortKey="Tan, Eng King" sort="Tan, Eng King" uniqKey="Tan E" first="Eng-King" last="Tan">Eng-King Tan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Singapore General Hospital, Singapore. gnrtek@sgh.com.sg</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Department of Neurology, Singapore General Hospital</wicri:regionArea>
<wicri:noRegion>Singapore General Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ho, Su Chin" sort="Ho, Su Chin" uniqKey="Ho S" first="Su-Chin" last="Ho">Su-Chin Ho</name>
</author>
<author><name sortKey="Koh, Leonard" sort="Koh, Leonard" uniqKey="Koh L" first="Leonard" last="Koh">Leonard Koh</name>
</author>
<author><name sortKey="Pavanni, Ratnagopal" sort="Pavanni, Ratnagopal" uniqKey="Pavanni R" first="Ratnagopal" last="Pavanni">Ratnagopal Pavanni</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15378680</idno>
<idno type="pmid">15378680</idno>
<idno type="doi">10.1002/mds.20219</idno>
<idno type="wicri:Area/PubMed/Corpus">003338</idno>
<idno type="wicri:Area/PubMed/Curation">003338</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003567</idno>
<idno type="wicri:Area/Ncbi/Merge">000F50</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.</title>
<author><name sortKey="Tan, Eng King" sort="Tan, Eng King" uniqKey="Tan E" first="Eng-King" last="Tan">Eng-King Tan</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Singapore General Hospital, Singapore. gnrtek@sgh.com.sg</nlm:affiliation>
<country xml:lang="fr">Singapour</country>
<wicri:regionArea>Department of Neurology, Singapore General Hospital</wicri:regionArea>
<wicri:noRegion>Singapore General Hospital</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ho, Su Chin" sort="Ho, Su Chin" uniqKey="Ho S" first="Su-Chin" last="Ho">Su-Chin Ho</name>
</author>
<author><name sortKey="Koh, Leonard" sort="Koh, Leonard" uniqKey="Koh L" first="Leonard" last="Koh">Leonard Koh</name>
</author>
<author><name sortKey="Pavanni, Ratnagopal" sort="Pavanni, Ratnagopal" uniqKey="Pavanni R" first="Ratnagopal" last="Pavanni">Ratnagopal Pavanni</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ferritins (blood)</term>
<term>Humans</term>
<term>Hypothyroidism (drug therapy)</term>
<term>Iron (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination</term>
<term>Polysomnography</term>
<term>Restless Legs Syndrome (chemically induced)</term>
<term>Restless Legs Syndrome (diagnosis)</term>
<term>Risk Factors</term>
<term>Thyroid Function Tests</term>
<term>Thyroiditis, Autoimmune (drug therapy)</term>
<term>Thyroxine (adverse effects)</term>
<term>Thyroxine (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Thyroxine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Ferritins</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Hypothyroidism</term>
<term>Thyroiditis, Autoimmune</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Iron</term>
<term>Thyroxine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neurologic Examination</term>
<term>Polysomnography</term>
<term>Risk Factors</term>
<term>Thyroid Function Tests</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on the cause and effect relationship of restless legs syndrome (RLS) with L-thyroxine treatment in a hypothyroid patient with low serum ferritin. Upon challenge and withdrawal of L-thyroxine, there was a significant change in the International Restless Legs Syndrome Study Group severity score (26/40 to 6/40), the periodic limb movements (PMLS) index (20/hour to 10/hour), the number of arousals due to PLMS (59 to 22), sleep efficiency (74 to 85%), and biochemical parameters. RLS symptoms can complicate thyroxine replacement in at-risk hypothyroid patients with low serum ferritin. Early diagnosis and iron replacement could significantly reduce patient morbidity.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">15378680</PMID>
<DateCreated><Year>2004</Year>
<Month>11</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>02</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>19</Volume>
<Issue>11</Issue>
<PubDate><Year>2004</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.</ArticleTitle>
<Pagination><MedlinePgn>1365-7</MedlinePgn>
</Pagination>
<Abstract><AbstractText>We report on the cause and effect relationship of restless legs syndrome (RLS) with L-thyroxine treatment in a hypothyroid patient with low serum ferritin. Upon challenge and withdrawal of L-thyroxine, there was a significant change in the International Restless Legs Syndrome Study Group severity score (26/40 to 6/40), the periodic limb movements (PMLS) index (20/hour to 10/hour), the number of arousals due to PLMS (59 to 22), sleep efficiency (74 to 85%), and biochemical parameters. RLS symptoms can complicate thyroxine replacement in at-risk hypothyroid patients with low serum ferritin. Early diagnosis and iron replacement could significantly reduce patient morbidity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName>
<ForeName>Eng-King</ForeName>
<Initials>EK</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Singapore General Hospital, Singapore. gnrtek@sgh.com.sg</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ho</LastName>
<ForeName>Su-Chin</ForeName>
<Initials>SC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Koh</LastName>
<ForeName>Leonard</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Pavanni</LastName>
<ForeName>Ratnagopal</ForeName>
<Initials>R</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>9007-73-2</RegistryNumber>
<NameOfSubstance UI="D005293">Ferritins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>E1UOL152H7</RegistryNumber>
<NameOfSubstance UI="D007501">Iron</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Q51BO43MG4</RegistryNumber>
<NameOfSubstance UI="D013974">Thyroxine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005293">Ferritins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007037">Hypothyroidism</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007501">Iron</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D017286">Polysomnography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012148">Restless Legs Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012307">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013960">Thyroid Function Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013967">Thyroiditis, Autoimmune</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013974">Thyroxine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>2</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>9</Month>
<Day>21</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15378680</ArticleId>
<ArticleId IdType="doi">10.1002/mds.20219</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Singapour</li>
</country>
</list>
<tree><noCountry><name sortKey="Ho, Su Chin" sort="Ho, Su Chin" uniqKey="Ho S" first="Su-Chin" last="Ho">Su-Chin Ho</name>
<name sortKey="Koh, Leonard" sort="Koh, Leonard" uniqKey="Koh L" first="Leonard" last="Koh">Leonard Koh</name>
<name sortKey="Pavanni, Ratnagopal" sort="Pavanni, Ratnagopal" uniqKey="Pavanni R" first="Ratnagopal" last="Pavanni">Ratnagopal Pavanni</name>
</noCountry>
<country name="Singapour"><noRegion><name sortKey="Tan, Eng King" sort="Tan, Eng King" uniqKey="Tan E" first="Eng-King" last="Tan">Eng-King Tan</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F50 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000F50 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:15378680
   |texte=   An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:15378680" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.

An urge to move with L-thyroxine: clinical, biochemical, and polysomnographic correlation.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki